Qube reports 2,930,140 Class B shares in Brera (NASDAQ: SLMT)

Rhea-AI Filing Summary

Qube Research & Technologies Limited and Pierre‑Yves Morlat report beneficial ownership of 2,930,140 Class B Ordinary Shares of Brera Holdings PLC, representing 3.6% of the class. The filing states shared voting and shared dispositive power over these shares and references a previously filed power of attorney. The statement is an amendment to a Schedule 13G/A and is signed by an authorized representative on 05/15/2026.

Insights

Institutional Ownership Analyst

Institutional holder reports a 3.6% stake with shared voting power.

Qube Research & Technologies Limited discloses beneficial ownership of 2,930,140 shares of Class B Ordinary Shares, with both shared voting and shared dispositive authority listed. The filing ties these holdings to QRT Funds for which QRT is investment manager and identifies Mr. Morlat as QRT's CEO.

The filing is administrative: it records holdings and voting/dispositive arrangements and references a prior power of attorney. Subsequent filings or amendments would be the source for changes in stake or voting structure.

Compliance & Reporting Specialist

Amendment clarifies reporting relationships and attests to comparable foreign regulation.

The amendment incorporates identification details for the reporting persons and affirms that QRT's foreign regulatory scheme is substantially comparable to U.S. counterparts, plus an undertaking to furnish Schedule 13D information if requested. Signatures show authorization via a previously filed power of attorney.

This is procedural and does not by itself change holdings; review of underlying fund documents or later amendments would disclose any change in voting arrangements or additional transfers.

Key Figures

Beneficial ownership: 2,930,140 shares Percent of class: 3.6% Nominal value: $0.05 per share +1 more

4 metrics

Beneficial ownership 2,930,140 shares Class B Ordinary Shares

Percent of class 3.6% Percentage of Class B Ordinary Shares

Nominal value $0.05 per share Class B Ordinary Shares nominal value

Signature date 05/15/2026 Date of authorized signature on amendment

Key Terms

Schedule 13G/A, Shared dispositive power, Power of Attorney, Beneficial ownership

4 terms

Schedule 13G/A regulatory

"This Statement is filed on behalf of each of the following persons"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

Shared dispositive power financial

"Shared Dispositive Power 2,930,140.00"

Power of Attorney legal

"signing on behalf of Pierre-Yves Morlat as attorney-in-fact pursuant to a Power of Attorney"

A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.

Beneficial ownership regulatory

"Amount beneficially owned: 2,930,140"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/15/2026 - 09:24 AM Learn about SEC filing dates

FAQ

What stake does Qube Research reported in Brera Holdings (SLMT)?

Qube Research and Pierre‑Yves Morlat report beneficial ownership of 2,930,140 Class B shares, equal to 3.6% of the class. The filing lists shared voting and shared dispositive power over these shares according to the Schedule 13G/A amendment.

Who holds voting and dispositive power for the reported shares?

The filing states the shares are held with shared voting power and shared dispositive power of 2,930,140 shares. Sole voting and sole dispositive powers are reported as 0, per the Schedule 13G/A amendment.

Which entities and individuals are named as reporting persons?

The Schedule 13G/A lists Qube Research & Technologies Limited and Pierre‑Yves Morlat as the Reporting Persons, with holdings held for QRT Master Fund SPC - Torus Fund SP and Qube Master Fund Ltd, and Mr. Morlat identified as QRT's CEO.

When was the amendment signed and by whom?

The amendment is signed on 05/15/2026 by Christina Wilgress, Director, who also signed as attorney‑in‑fact for Pierre‑Yves Morlat under a previously filed power of attorney incorporated by reference.

Does the filing indicate control by a parent or subsidiary?

The Schedule 13G/A references Item 7 guidance and states the response to Item 2 is incorporated by reference; it does not assert parent/ subsidiary control in the provided excerpt and lists the holdings as for QRT funds.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 2)

Brera Holdings PLC

(Name of Issuer)

Class B Ordinary Shares, $0.05 nominal value per share

(Title of Class of Securities)

G13311116

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): G13311116

1

Names of Reporting Persons

Qube Research & Technologies Ltd

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED KINGDOM

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 2,930,140.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 2,930,140.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,930,140.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

3.6 %

12

Type of Reporting Person (See Instructions)

FI

SCHEDULE 13G

CUSIP Number(s): G13311116

1

Names of Reporting Persons

Pierre-Yves Morlat

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

FRANCE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 2,930,140.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 2,930,140.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,930,140.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

3.6 %

12

Type of Reporting Person (See Instructions)

IN, HC

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Brera Holdings PLC
(b)	Address of issuer's principal executive offices: CONNAUGHT HOUSE, 5TH FLOOR, ONE BURLINGTON ROAD, DUBLIN 4, IRELAND, D04 C5Y6.
Item 2.
(a)	Name of person filing: This Statement is filed on behalf of each of the following persons (collectively, the "Reporting Persons"): i. Qube Research & Technologies Limited ("QRT"); and ii. Pierre-Yves Morlat ("Mr. Morlat"). This Statement relates to Class B Ordinary Shares ("Shares") held for the accounts of QRT Master Fund SPC - Torus Fund SP and Qube Master Fund Ltd. (collectively, the "QRT Funds") QRT serves as investment manager to each of the QRT Funds. Mr. Morlat is the Chief Executive Officer of QRT.
(b)	Address or principal business office or, if none, residence: 9 Bressenden Place, London, SW1E 5BY, United Kingdom
(c)	Citizenship: United Kingdom, France
(d)	Title of class of securities: Class B Ordinary Shares, $0.05 nominal value per share
(e)	CUSIP No.: G13311116
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
	Investment Adviser
Item 4.	Ownership
(a)	Amount beneficially owned: 2,930,140
(b)	Percent of class: 3.6%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 2,930,140
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 2,930,140
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. The response to Item 2 is incorporated by reference herein.
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ? 240.14a-11. By signing below I certify that, to the best of my knowledge and belief, the foreign regulatory scheme applicable to Qube Research & Technologies Limited is substantially comparable to the regulatory scheme applicable to the functionally equivalent U.S. institution(s). I also undertake to furnish to the Commission staff, upon request, information that would otherwise be disclosed in a Schedule 13D.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Qube Research & Technologies Ltd

Signature:	/s/ Christina Wilgress
Name/Title:	Christina Wilgress, Director
Date:	05/15/2026

Pierre-Yves Morlat

Signature:	/s/ Christina Wilgress
Name/Title:	Christina Wilgress, attorney-in-fact for Pierre-Yves Morlat*
Date:	05/15/2026

Comments accompanying signature: *Christina Wilgress is signing on behalf of Pierre-Yves Morlat as attorney-in-fact pursuant to a Power of Attorney previously filed with the Securities and Exchange Commission, and hereby incorporated by reference herein. The power of attorney was filed as an attachment to a filing by Qube Research & Technologies Ltd on Schedule 13G for Brera Holdings PLC on February 17, 2026.